Related Experiment Video
Updated: Aug 9, 2026

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia
L H Castilla1, P Perrat, N J Martinez
1Program in Gene Function and Expression, University of Massachusetts Medical School, Worcester, MA 01605, USA. lucio.castilla@umassmed.edu
Abstract:
Acute myeloid leukemia subtype M4 with eosinophilia is associated with a chromosome 16 inversion that creates a fusion gene CBFB-MYH11. We have previously shown that CBFB-MYH11 is necessary but not sufficient for leukemogenesis. Here, we report the identification of genes that specifically cooperate with CBFB-MYH11 in leukemogenesis. Neonatal injection of Cbfb-MYH11 knock-in chimeric mice with retrovirus 4070A led to the development of acute myeloid leukemia in 2-5 months. Each leukemia sample contained one or a few viral insertions, suggesting that alteration of one gene could be sufficient to synergize with Cbfb-MYH11. The chromosomal position of 67 independent retroviral insertion sites (RISs) was determined, and 90% of the RISs mapped within 10 kb of a flanking gene. In total, 54 candidate genes were identified; six of them were common insertion sites (CISs). CIS genes included members of a zinc finger transcription factors family, Plag1 and Plagl2, with eight and two independent insertions, respectively. CIS genes also included Runx2, Myb, H2T24, and D6Mm5e. Comparison of the remaining 48 genes with single insertion sites with known leukemia-associated RISs indicated that 18 coincide with known RISs. To our knowledge, this retroviral genetic screen is the first to identify genes that cooperate with a fusion gene important for human myeloid leukemia.
Insights
Researchers identified genes cooperating with the CBFB-MYH11 fusion gene in acute myeloid leukemia (AML). This retroviral screen in mice revealed specific genetic alterations that synergize with CBFB-MYH11 to cause leukemia, advancing our understanding of AML pathogenesis.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- Acute myeloid leukemia (AML) subtype M4 with eosinophilia involves a chromosome 16 inversion creating the CBFB-MYH11 fusion gene.
- The CBFB-MYH11 fusion gene is essential but not sufficient for causing leukemia.
Purpose of the Study:
- To identify genes that cooperate with CBFB-MYH11 in leukemogenesis.
- To understand the genetic mechanisms driving AML development in the presence of the CBFB-MYH11 fusion.
Main Methods:
- Utilized a retroviral genetic screen in Cbfb-MYH11 knock-in chimeric mice.
- Administered retrovirus 4070A to neonatal mice, inducing AML development within 2-5 months.
- Determined the chromosomal positions of 67 independent retroviral insertion sites (RISs) to identify cooperating genes.
Main Results:
- Identified 54 candidate genes cooperating with CBFB-MYH11, with 90% of RISs located near a gene.
- Six common insertion sites (CISs) were identified, including zinc finger transcription factors PLAG1 and PLAGL2, RUNX2, and MYB.
- 18 of the 48 genes with single insertion sites coincided with known leukemia-associated RISs.
Conclusions:
- This study presents the first retroviral genetic screen to identify cooperating genes for a fusion gene critical in human myeloid leukemia.
- The findings highlight specific genes that, when altered, synergize with CBFB-MYH11 to drive leukemogenesis.
- This research provides insights into the complex genetic landscape of AML and potential therapeutic targets.
Related Concept Videos
Master Transcription Regulators
Abnormal Proliferation
Differentiation of Common Myeloid Progenitor Cells

